Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Double-blind, Randomized Controlled Trial of Inhaled Amikacin Versus Placebo in Critically Ill Patients With Ventilator-associated Tracheobronchitis

NCT07665788 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT07665788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07665788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Double-blind, Randomized Controlled Trial of Inhaled Amikacin Versus Placebo in Critically Ill Patients With Ventilator-associated Tracheobronchitis
Lead sponsor
University Hospital, Tours
Phase
Phase 3
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
September 1, 2029
Enrollment
250 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

ventilator-associated pneumonia, ventilator-associated tracheobronchitis